# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001907030 (5,42)

Office of origin: United States of America

Date of International Registration:20 January 2026
Date of designation in the UK: 20 January 2026

International priority date claimed: 21 July 2025 (United States of America) (99295160)

Class 5
  Pharmaceutical preparations for the treatment and diagnosis of oncological and immunological diseases.
Class 42
  Pharmaceutical research and development; biotechnology research in the field of pharmaceutical product research and development of drug therapies and diagnostic tests for the treatment of oncological and immunological diseases.

Endevica Bio, Inc.

Representative: Chelseaa Larsen Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA